MHRA Drug Safety Update January 2019

MHRA Drug Safety Update January 2019

January 10, 2019

Date issued 9th January 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 6 January 2019:1) has been published and includes articles on:

  • Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines.
  • Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation
  • Yellow Card App: download the updated App to receive the latest MHRA safety news and report suspected side effects, including in pregnancy
  • Letters and drug alerts sent to healthcare professionals in December 2018
  • Medical Device Alerts issued in December 2018

To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.

 



Posted in:


More Latest News >

Ask PSNC: Quality Payments FAQs

The team at PSNC has received a number of queries on the Quality Payments Scheme. Below are some of the questions asked in recent weeks....